Erratum to

Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden (International Journal of Hematology, (2016), 104, 6, (700-708), 10.1007/s12185-016-2097-9)

Tadahiko Igarashi, Michinori Ogura, Kuniaki Itoh, Masafumi Taniwaki, Kiyoshi Ando, Yoshiaki Kuroda, Kazuhito Yamamoto, Naokuni Uike, Akihiro Tomita, Hirokazu Nagai, Mitsutoshi Kurosawa, Shigeo Mori, Shigeru Nawano, Takashi Terauchi, Yasuo Ohashi, Kensei Tobinai

Research output: Contribution to journalComment/debate

Abstract

The authors would like to correct the errors in the publication of the original article. The corrected details are given below for your reading. The Clinical trial number should be “UMIN000001603” at the end of Abstract and in the last sentence of the paragraph heading “Study design and patients” under “Materials and methods” section. Secondly, the Fig. 1 was incorrectly published with the meaningless red font. The corrected figure is given below: (Figure presented.).

Original languageEnglish
Pages (from-to)109-110
Number of pages2
JournalInternational Journal of Hematology
Volume105
Issue number1
DOIs
Publication statusPublished - 01-01-2017

Fingerprint

B-Cell Lymphoma
Hematology
Tumor Burden
Non-Hodgkin's Lymphoma
Publications
Reading
Maintenance
Clinical Trials
Rituximab

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Igarashi, Tadahiko ; Ogura, Michinori ; Itoh, Kuniaki ; Taniwaki, Masafumi ; Ando, Kiyoshi ; Kuroda, Yoshiaki ; Yamamoto, Kazuhito ; Uike, Naokuni ; Tomita, Akihiro ; Nagai, Hirokazu ; Kurosawa, Mitsutoshi ; Mori, Shigeo ; Nawano, Shigeru ; Terauchi, Takashi ; Ohashi, Yasuo ; Tobinai, Kensei. / Erratum to : Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden (International Journal of Hematology, (2016), 104, 6, (700-708), 10.1007/s12185-016-2097-9). In: International Journal of Hematology. 2017 ; Vol. 105, No. 1. pp. 109-110.
@article{17c90acde36e44e3b206ca526a03dc36,
title = "Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden (International Journal of Hematology, (2016), 104, 6, (700-708), 10.1007/s12185-016-2097-9)",
abstract = "The authors would like to correct the errors in the publication of the original article. The corrected details are given below for your reading. The Clinical trial number should be “UMIN000001603” at the end of Abstract and in the last sentence of the paragraph heading “Study design and patients” under “Materials and methods” section. Secondly, the Fig. 1 was incorrectly published with the meaningless red font. The corrected figure is given below: (Figure presented.).",
author = "Tadahiko Igarashi and Michinori Ogura and Kuniaki Itoh and Masafumi Taniwaki and Kiyoshi Ando and Yoshiaki Kuroda and Kazuhito Yamamoto and Naokuni Uike and Akihiro Tomita and Hirokazu Nagai and Mitsutoshi Kurosawa and Shigeo Mori and Shigeru Nawano and Takashi Terauchi and Yasuo Ohashi and Kensei Tobinai",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/s12185-016-2155-3",
language = "English",
volume = "105",
pages = "109--110",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "1",

}

Erratum to : Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden (International Journal of Hematology, (2016), 104, 6, (700-708), 10.1007/s12185-016-2097-9). / Igarashi, Tadahiko; Ogura, Michinori; Itoh, Kuniaki; Taniwaki, Masafumi; Ando, Kiyoshi; Kuroda, Yoshiaki; Yamamoto, Kazuhito; Uike, Naokuni; Tomita, Akihiro; Nagai, Hirokazu; Kurosawa, Mitsutoshi; Mori, Shigeo; Nawano, Shigeru; Terauchi, Takashi; Ohashi, Yasuo; Tobinai, Kensei.

In: International Journal of Hematology, Vol. 105, No. 1, 01.01.2017, p. 109-110.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - Erratum to

T2 - Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden (International Journal of Hematology, (2016), 104, 6, (700-708), 10.1007/s12185-016-2097-9)

AU - Igarashi, Tadahiko

AU - Ogura, Michinori

AU - Itoh, Kuniaki

AU - Taniwaki, Masafumi

AU - Ando, Kiyoshi

AU - Kuroda, Yoshiaki

AU - Yamamoto, Kazuhito

AU - Uike, Naokuni

AU - Tomita, Akihiro

AU - Nagai, Hirokazu

AU - Kurosawa, Mitsutoshi

AU - Mori, Shigeo

AU - Nawano, Shigeru

AU - Terauchi, Takashi

AU - Ohashi, Yasuo

AU - Tobinai, Kensei

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The authors would like to correct the errors in the publication of the original article. The corrected details are given below for your reading. The Clinical trial number should be “UMIN000001603” at the end of Abstract and in the last sentence of the paragraph heading “Study design and patients” under “Materials and methods” section. Secondly, the Fig. 1 was incorrectly published with the meaningless red font. The corrected figure is given below: (Figure presented.).

AB - The authors would like to correct the errors in the publication of the original article. The corrected details are given below for your reading. The Clinical trial number should be “UMIN000001603” at the end of Abstract and in the last sentence of the paragraph heading “Study design and patients” under “Materials and methods” section. Secondly, the Fig. 1 was incorrectly published with the meaningless red font. The corrected figure is given below: (Figure presented.).

UR - http://www.scopus.com/inward/record.url?scp=84997637174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997637174&partnerID=8YFLogxK

U2 - 10.1007/s12185-016-2155-3

DO - 10.1007/s12185-016-2155-3

M3 - Comment/debate

VL - 105

SP - 109

EP - 110

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 1

ER -